domingo, 2 de octubre de 2022

COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study - The Lancet Gastroenterology & Hepatology

COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study - The Lancet Gastroenterology & Hepatology

No hay comentarios:

Publicar un comentario